Reviews November 8, 2026

Peptide Confidential Review: Canadian Prices, Lot Records and COAs

Our Peptide Confidential review checks Canadian-dollar prices, current and historical lot records, original laboratory documents and product coverage.


We reviewed Peptide Confidential, its complete catalog, the lot ledger, every linked original document and the relevant independent provider records. Its strongest feature is a substantial batch history that preserves rejected and withdrawn records alongside released lots.

Scope and disclosure

Reviewed November 8, 2026 using an existing researcher account. The catalog and lot library require sign-in, while the linked PDF files are publicly readable. We did not purchase products, independently test samples or verify delivery.

Affiliate disclosure added November 16, 2026. PeptideBenchmark may earn commission on eligible orders through its Peptide Confidential referral link. For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.

46unique catalog SKUs
20orderable vial offers compared
61published lot records
57distinct linked document bodies
39independently verified documents
26documented exact product matches
PB assessmentA useful, checkable lot history, with narrower product coverage and important limits on what each document establishes.

A large library is valuable, but a matching laboratory record, a matching product formulation and a supplier's release decision are separate findings.

Catalog and prices

The catalog displayed 47 listings. One Kisspeptin link redirected to the same SKU as another listing, leaving 46 unique SKUs. Of these, 21 were orderable and 25 were unavailable. All orderable products had a usable nominal vial quantity after reviewing their own descriptions, labels and linked documents. The 5+5 mg BPC-157/TB-500 blend remains outside comparison pricing because its current label and report do not resolve the TB-500 molecular form; an older batch record cannot establish the current formulation. No ready spray, capsule, tablet or IU presentation was found.

The pricing board and Stack Builder compare 20 orderable single-vial offers. The store’s regular prices are in CAD; this review used 0.71092 USD per CAD, dated November 6, 2026, from Frankfurter. The vendor’s approximate USD display and a card processor’s eventual exchange rate are separate figures.

The store advertises quantity discounts, including mixed-vial orders. Those savings and conditional welcome or email offers were not certified in a cart and are not included in the comparison price. Unavailable products do not become current offers merely because a price remains visible. Cerebrolysim’s precise material identity and SNAP-8’s nominal vial quantity remain unresolved in the unavailable catalog; neither is promoted as an active offer.

What the lot library establishes

The ledger contained 52 released, two withdrawn and seven rejected records. Its 60 document-bearing records linked to 57 distinct PDF bodies; the remaining record published no laboratory document. Repeated links and different presentations are retained without counting the same physical file repeatedly.

The files comprise 35 Peptide Test Canada presentations of SideChain Analytics analyses, seven Horizon Analytical documents, two PacifiCOA Analytics documents and 13 Testides-related documents. The Testides group includes nine analytical evidence reports and four saved or reformatted verification-page copies. A PDF heading alone does not make a saved page an original certificate.

We resolved the exact printed provider credentials and compared the original documents, scientific fields and named parties. 39 document bodies satisfied the verification standard. Four other documents differed from the testing laboratory’s available edition in purity values or dates; their published results remain attributed to their source, without an exact-match verification badge. One further laboratory original uses a personal name in place of the approved vendor client label. That alias has not been established in this review, so the document receives no exact client-match credit. Laboratory and distributor editions are preserved separately.

Testides independently confirmed the printed report numbers and recorded purity and mass values. Its public verification response does not disclose who submitted the sample. That confirmation remains useful, but it does not establish the vendor’s client attribution or transform a reformatted printout into an original laboratory certificate.

The reviewed CJC-1295 lot linked to the same PDF as a GHK-Cu 100 mg lot. The document identifies GHK-Cu, so it does not establish CJC-1295 coverage. We rechecked both links before recording this finding.

The library-only SideChain record without a published document is retained as an explicit gap. A separately located laboratory original under that report number does not establish Peptide Confidential sample ownership, and it is not substituted for a vendor-published file.

Product coverage and analytical limits

Exact nominal compound, quantity and applicable formulation matches were established for 26 catalog SKUs. Historical documentation remains historical; it does not establish that the next shipment contains the tested lot. A matching name or total blend mass does not resolve an unspecified component allocation or molecular form.

The records distinguish chromatographic purity from measured peptide content and identity. Rejected and withdrawn records remain visible as historical evidence, rather than being treated as current stock. Component results remain individual observations; they are not averaged into a purported scalar blend purity.

The reviewed documents do not establish completed sterility, endotoxin or heavy-metal testing. In particular, a method named beside “not tested” is not a performed assay. These gaps, narrower exact product coverage and differences between document editions matter alongside the library’s size.

The live vendor profile carries the current score and evidence totals. Individual COA records retain original documents, measurements and verification status. See our methodology for how those different forms of evidence contribute to the benchmark.

Business and fulfillment

The vendor identifies its operator as 2834467 Alberta Incorporated in Calgary, Alberta. This is a published business statement, not independent verification of a manufacturing or fulfillment facility.

The reviewed shipping policy lists Canada Post Xpresspost within Canada and supported international destinations, with final availability confirmed at checkout. It states free shipping on goods of CA$200 or more after discounts, and an aim of same-day dispatch when payment is confirmed before 1 p.m. Mountain Time, Monday through Saturday. Customs, duties, destination restrictions and international delivery conditions still apply. Dispatch and delivery have not been independently tested.

The replacement policy describes remedies for damaged, incorrect or confirmed-lost shipments and a separate replacement process for qualifying independent-testing disputes. These are vendor policies, not fulfillment outcomes observed by PeptideBenchmark.

Common questions

Can Peptide Confidential reports be independently checked?

Yes, many of the published PDFs match independent provider records and scientific fields. Other documents have differing laboratory editions or are saved or reformatted verification pages. The live profile distinguishes published documents from independently verified evidence.

Are the prices in Canadian or U.S. dollars?

The store lists Canadian-dollar prices. PeptideBenchmark converts the regular single-vial price to U.S. dollars using a dated exchange rate. Advertised quantity discounts, conditional codes and payment conversion fees are excluded.

Does a released lot or high purity establish sterility?

No. Release status is the supplier's decision. Purity, identity, measured content, sterility, endotoxin and heavy metals are separate questions, and a report applies to the submitted sample.